Last updated on May 2018

Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)


Brief description of study

In this study, participants with Stage IB/II-IIIA non-small cell lung cancer (NSCLC) who have undergone surgical resection (lobectomy or pneumonectomy) with or without adjuvant chemotherapy will be treated with pembrolizumab or placebo. The primary study hypothesis is that pembrolizumab will provide improved disease-free survival (DFS) versus placebo.

Clinical Study Identifier: NCT02504372

Contact Investigators or Research Sites near you

Start Over

Klaudia Georgi

MSD Osterreich GmbH
Vienna, Austria
  Connect »

Erik Antonissen

MSD Belgium BVBA/SPRL
Brussels, Belgium
  Connect »

Katrin Moeschlin

Merck Sharp & Dohme
Glostrup, Denmark
  Connect »

Katrin Moeschlin

Merck Sharp & Dohme OU
Tallinn, Estonia
  Connect »

Valerie Bouchara

MSD France
Paris, France
  Connect »

German Medical Information Center

MSD Sharp & Dohme GmbH
Haar, Germany
  Connect »

Anna Aletra

Vianex, S.A. / MSD
Alimos, Greece
  Connect »

Szabolcs Barotfi

MSD Pharma Hungary Kft.
Budapest, Hungary
  Connect »

Paul Duffy

MSD Ireland (Human Health) Ltd.
Dublin, Ireland
  Connect »

Dan Goldstaub

Merck Sharp & Dohme Co. Ltd.
Hod Hasharon, Israel
  Connect »

Paola Chiaretta Fattore

MSD Italia S.r.l.
Rome, Italy
  Connect »

Japan Call Center

MSD K.K.
Chiyoda-Ku, Tokyo, Japan
  Connect »

Katrin Moeschlin

Merck Sharp & Dohme Latvija SIA
Riga, Latvia
  Connect »

Arjan Ooms

Merck Sharp & Dohme BV
Haarlem, Netherlands
  Connect »

Thomas J. Johansson

MSD Polska Sp. Z o.o.
Warsaw, Poland
  Connect »

Szabolcs Barotfi

MSD Inovativna zdravilla
Ljubljana, Slovenia
  Connect »

Lourdes Lopez-Bravo

Merck Sharp and Dohme de Espana S.A.
Madrid, Spain
  Connect »

Klaudia Georgi

MSD International GmbH
Lucerne 6, Switzerland
  Connect »

Paul Duffy

Merck Sharp & Dohme Ltd.
Hoddesdon, United Kingdom
  Connect »

Australian Medical Information Centre

Merck Sharp & Dohme
North Ryde, Australia
  Connect »

TaeYoun Jo

MSD Korea LTD
Seoul, Korea, Republic of
  Connect »

Betul Erdogan

Merck Sharp & Dohme Ilaclari Ltd. Sti
Istanbul, Turkey
  Connect »

MSD Online

MSD Brasil
Sao Paulo, Brazil
  Connect »

Patricia Morales

Merck Sharp & Dohme (I.A.) Corp.
Santiago, Chile
  Connect »

Rodolfo Lozano

Merck Sharp & Dohme, Peru S.R.L.
Lima, Peru
  Connect »

Tatiana Serebriakova

Merck Sharp & Dohme IDEA, Inc.
Moscow, Russian Federation
  Connect »

Thomas J. Johansson

MSD SRO Czech
Prague, Czechia
  Connect »

Lourdes Lopez-Bravo

Merck Sharp & Dohme Lda.
Paco D'arcos, Portugal
  Connect »